Similar Articles
1111 Update in management of hepatocellular carcinoma in Eastern population
1112 Th1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinoma
1113 Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma
1114 Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma
1115 Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients
1116 Liver transplantation as a management of hepatocellular carcinoma
1117 Chemokines and their receptors play important roles in the development of hepatocellular carcinoma
1118 Current systemic treatment of hepatocellular carcinoma: A review of the literature
1119 Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease
1120 Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA